Nonalcoholic Fatty Liver Disease — An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
Citation(s)
Effects of Compound Silymarin on Biomarkers of Lipid Metabolism and Inflammation in Patients With Non-alcoholic Fatty Liver Disease: A Randomized Controlled Double-blind Trial